Regulations.gov document
NDI 114 - BioDiamed (Mormadica charantia L.) from Kelatron Corporation World Headquarters
Other · FDA-2002-S-0531 · posted Jan 10, 2017
Key facts
| Document ID | FDA-2002-S-0531-0039 |
|---|---|
| Title | NDI 114 - BioDiamed (Mormadica charantia L.) from Kelatron Corporation World Headquarters |
| Document type | Other |
| Subtype | 75 Day PreMarket Notification |
| Agency | FDA |
| Docket | FDA-2002-S-0531 |
| Posted | Jan 10, 2017 |
| Comment period opens | Jan 10, 2017 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: